Loading...
XKRX
036220
Market cap51mUSD
Jul 10, Last price  
5,900.00KRW
1D
4.61%
1Q
-29.76%
IPO
-85.26%
Name

Osang HealthCare Co Ltd

Chart & Performance

D1W1MN
XKRX:036220 chart
P/E
P/S
EPS
225.92
Div Yield, %
Shrs. gr., 5y
1.92%
Rev. gr., 5y
-12.99%
Revenues
128.63b
+59.81%
59,073,745,85254,339,923,23056,145,505,37157,268,998,638257,967,344,000132,326,879,000193,893,073,000355,846,883,00080,488,365,000128,628,729,000
Net income
3.11b
P
-10,901,034,2478,848,437,7482,146,291,155-4,224,368,776124,996,259,0001,460,426,00040,646,921,000116,435,776,000-11,364,443,0003,106,565,000
CFO
6.21b
P
3,093,067,781-460,330,576971,802,0335,293,698,000101,161,765,00010,807,352,00042,353,497,000152,595,520,000-38,767,363,0006,213,106,000
Dividend
Dec 27, 2024500 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Osang Healthcare Co.,Ltd, based in Anyang, South Korea, is a company focused on the innovation, advancement, and global commercialization of diverse diagnostic biosensing solutions. Their comprehensive product offerings include tests for key health markers such as blood glucose, hemoglobin A1c, and cholesterol, in addition to sophisticated immuno- and molecular diagnostic technologies. These cutting-edge products reach approximately 110 nations across the globe. Established in 1996, the firm operated as Infopia Co., Ltd. until its rebranding to Osang Healthcare Co.,Ltd in April 2017.
IPO date
Jun 05, 2007
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT